long-acting insulin substitutes." Last November, Novo Nordisk announced it would stop selling the injectable FlexPen version of Levemir this month and halt sales of Levemir vials by December 2024.

The drugmaker will stop selling the injectable FlexPen version of Levemir in April and will halt sales of Levemir vials ...

Update (November 13, 2023): Novo Nordisk announced that it will discontinue the Levemir Flex Pen in the United States on April 1, 2024, and the vial on December 31, 2024. It expects supply ...

the insulin maker plans to discontinue U.S. sales of the FlexPen version of Levemir in April 2024 and Levemir vials by the ...

A trio of Democratic senators want Novo Nordisk to explain why it discontinued one of its long-acting insulin products after it announced a steep price cut on the medication. Sens. Jeanne Shaheen ...

followed by discontinuation of the Levemir injection pen in April and of Levemir vials by the end of 2024. Novo has another long-acting insulin, Tresiba, on the market. "Novo Nordisk will phase out, ...

Under Congressional pressure, the price of insulin has come down in recent months, which is good news for diabetics and others who depend on it. In 2023, Novo Nordisk announced that it would ...

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities Cheaper private Covid jabs could end up being just as expensive as their pricier ...

Opens in a new tab or window Both generic and branded formulations of 10-mL vials of insulin lispro injection (Humalog) will be temporarily out of stock through the start of April, Eli Lilly ...

If you are using the frozen pre-mixed solution, thaw the bag at room temperature ... It is important to get each dose of this medication as scheduled. If you miss a dose, ask your doctor or ...

Amneal Pharmaceuticals announced on March 27, 2024 that it was voluntarily recalling four lots of Vancomycin Hydrochloride for Oral Solution ... maximum daily dose allowance is 2 gm per day. If ...